Optic Nerve Disorders Drugs Market: Dynamics

The growing incidences of optic nerve disorders are the demand drivers of the optic nerve disorders drugs market. Optic neuritis affects adults between the ages of 25 to 45 years. The incidence rate of optic neuritis is 5 out of 100000 each year. Almost 3 million Americans suffer from glaucoma resulting in more than 120,000 blind patients and accounting for 9% to 12% of all cases of blindness. According to the World Health Organization, Glaucoma is the second leading cause of blindness in the world after cataracts. The large economic burden of optic nerve disorders is another driver of the optic nerve disorders drugs market. Glaucoma alone accounts for over 10 million physician’s visits each year in the U.S. and costs over $1.5 billion annually in terms of lost income social security benefits,, and health care expenditures.

Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2689 

Source: Click here